Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology
|
January 4, 2011
17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development
Sandrine Marchais-Oberwinkler, Claudia Henn, Gabriele Möller, et al.
ACS Chemical Neuroscience
|
May 12, 2018
Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules
Chia-Ju Hsieh, John J Ferrie, Kuiying Xu, et al.
Molecules (Basel, Switzerland)
|
December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response
Aladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Cancer Research
|
June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy
Mehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
International Journal of Molecular Sciences
|
May 11, 2024
Positron Emission Tomography with [<sup>18</sup>F]ROStrace Reveals Progressive Elevations in Oxidative Stress in a Mouse Model of Alpha-Synucleinopathy
Evan Gallagher, Catherine Hou, Yi Zhu, et al.
ACS Chemical Neuroscience
|
November 4, 2017
Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation
Catherine Hou, Chia-Ju Hsieh, Shihong Li, et al.
EJNMMI Physics
|
October 9, 2018
Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [<sup>18</sup>F]fluortriopride
Robert K Doot, Jacob G Dubroff, Joshua S Scheuermann, et al.
Journal of Medicinal Chemistry
|
April 26, 2019
Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)
Sean W Reilly, Aladdin A Riad, Chia-Ju Hsieh, et al.
Molecular Cancer Therapeutics
|
May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models
Mehran Makvandi, Hwan Lee, Laura N Puentes, et al.
The Journal of Clinical Investigation
|
March 7, 2018
A PET imaging agent for evaluating PARP-1 expression in ovarian cancer
Mehran Makvandi, Austin Pantel, Lauren Schwartz, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
The Journal of Steroid Biochemistry and Molecular Biology
|
January 4, 2011
17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development
Sandrine Marchais-Oberwinkler, Claudia Henn, Gabriele Möller, et al.
ACS Chemical Neuroscience
|
May 12, 2018
Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules
Chia-Ju Hsieh, John J Ferrie, Kuiying Xu, et al.
Molecules (Basel, Switzerland)
|
December 23, 2020
PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response
Aladdin Riad, Sarah B Gitto, Hwan Lee, et al.
Cancer Research
|
June 5, 2016
A Radiotracer Strategy to Quantify PARP-1 Expression In Vivo Provides a Biomarker That Can Enable Patient Selection for PARP Inhibitor Therapy
Mehran Makvandi, Kuiying Xu, Brian P Lieberman, et al.
International Journal of Molecular Sciences
|
May 11, 2024
Positron Emission Tomography with [<sup>18</sup>F]ROStrace Reveals Progressive Elevations in Oxidative Stress in a Mouse Model of Alpha-Synucleinopathy
Evan Gallagher, Catherine Hou, Yi Zhu, et al.
ACS Chemical Neuroscience
|
November 4, 2017
Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation
Catherine Hou, Chia-Ju Hsieh, Shihong Li, et al.
EJNMMI Physics
|
October 9, 2018
Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [<sup>18</sup>F]fluortriopride
Robert K Doot, Jacob G Dubroff, Joshua S Scheuermann, et al.
Journal of Medicinal Chemistry
|
April 26, 2019
Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)
Sean W Reilly, Aladdin A Riad, Chia-Ju Hsieh, et al.
Molecular Cancer Therapeutics
|
May 11, 2019
Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models
Mehran Makvandi, Hwan Lee, Laura N Puentes, et al.
The Journal of Clinical Investigation
|
March 7, 2018
A PET imaging agent for evaluating PARP-1 expression in ovarian cancer
Mehran Makvandi, Austin Pantel, Lauren Schwartz, et al.
Page
of 5